How to suspect transthyretin cardiac amyloidosis during daily clinical practice

Early diagnosis of wild-type transthyretin cardiac amyloidosis remains clinically challenging but is now of highest importance given the recently-reported favorable prognostic impact of tafamidis [1]. Ladefoged and colleagues demonstrated that the diagnostic delay in cardiac amyloidosis was substantial, and prolonged diagnostic delay was associated with a higher clinical disease burden [2].
Source: International Journal of Cardiology - Category: Cardiology Authors: Tags: Letter to the Editor Source Type: research